On This Page
Meningococcal Disease: Technical & Clinical Information
Fever, headache and stiff neck in meningococcal meningitis cases, and sepsis and rash in meningococcemia.
Multiple serogroups of Neisseria meningitidis. Serogroups B, C, and Y cause the majority of disease in the United States. Serogroup W-135 causes a small portion of disease, and serogroup A causes disease in developing countries and the Meningitis Belt of subSaharan Africa.
Burden of disease
About 1000 cases annually in the United States during 2005-2010. Higher rates of disease in other countries. Largest burden in subSaharan Africa, where epidemics during the dry season can cause disease in up to 2% of a population, resulting in thousands of cases and deaths during large epidemics.
10%-14% of cases are fatal. Of patients who recover 11%-19% have permanent hearing loss, mental retardation, loss of limbs, or other serious sequelae.
N. meningitidis colonizes mucosal surfaces of nasopharynx and is transmitted through direct contact with large droplet respiratory secretions from the patients or asymptomatic carriers. Humans are the only host. Asymptomatic carriers who are not a close contact of a patient with meningococcal disease do not require prophylaxis.
Risk groups include household contacts of case patients, military recruits, college freshmen who live in dormitories, microbiologists who work with isolates of N. meningitidis, persons traveling to a country where meningococcal disease is epidemic or highly endemic, and patients without spleens or with terminal complement component deficiencies. Infants less than one year of age and adolescents ages 16 through 21 years have higher rates of disease than other age groups, but cases occur in all age groups including the elderly.
Meningococcal disease is a reportable condition in all US states. The local health department will conduct an investigation to ensure all close contacts are provided prophylaxis. See Active Bacterial Core surveillance reports.
Most Requested meningococcal references and resources, provider education tools, and materials for patients
- Clinical Factsheet
- Tools to assist health professionals in speaking with patients and their parents about adolescent vaccines
- Proper handling of MCV4 and MPSV4 vaccine
- Recommendations for prevention and control
ACIP recommendations, standing orders, contraindications...
- Vaccine References & Resources
- Provider Education
- Materials for Patients
- Healthcare Personnel Vaccination Recommendations [66 KB, 1 page]
- Guidelines for Vaccinating Pregnant Women
- Standing Orders
- ACIP – Vaccines for Children (VFC) Resolution
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.